Apontis Pharma AG (APPH) — Free Cash Flow Generation Index

Latest as of December 2024: 0.99x

Apontis Pharma AG (APPH) has a Free Cash Flow Generation Index of 0.99x as of December 2024. Free cash flow of €899.64K represents 1% of operating cash flow (€905.24K). Explore Apontis Pharma AG capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.99x
Free Cash Flow / Operating CF

Free Cash Flow

€899.64K
EUR

Operating Cash Flow

€905.24K
EUR

Capital Expenditures

€5.60K
EUR

Apontis Pharma AG Free Cash Flow Generation Index (2020–2022)

Historical FCF Generation Index trend for Apontis Pharma AG across 3 annual periods. For the full cash flow conversion analysis, see APPH cash generation efficiency.

Annual Free Cash Flow Generation for Apontis Pharma AG (2020–2022)

Year-by-year Free Cash Flow Generation Index for Apontis Pharma AG. Check Apontis Pharma AG total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (EUR) Operating CF Capital Expenditures YoY Change
2022 0.70x €7.74 Million €11.02 Million €3.28 Million ▲ +36.0%
2021 0.52x €1.77 Million €3.43 Million €1.66 Million ▲ +3.9%
2020 0.50x €721.45K €1.45 Million €729.56K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).